Vol 8, No 2 (2012)

March/April

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Articles

Physician survey examining the impact of an educational tool for responsible opioid prescribing
Aaron Young, PhD, Kelly C. Alfred, MS, Philip P. Davignon, MA, LaSharn M. Hughes, MBA, Lisa A. Robin, MLA, Humayun J. Chaudhry, DO
PDF
81-87
Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain
Felix A. de la Iglesia, MD, Gary W. Pace, PhD, Gary L. W. G. Robinson, PhD, Nuo-Yu Huang, MD, PhD, Warren Stern, PhD, Patricia Richards, MD, PhD
PDF
89-98
Continuous hydromorphone for pain and sedation in mechanically ventilated infants and children
Pamela D. Reiter, PharmD, Jennifer Ng, PharmD, Emily L. Dobyns, MD
PDF
99-104
A comparative study on the effects of intrathecal morphine added to levobupivacaine for spinal anesthesia
Hakki Unlugenc, MD, Murat Gunduz, MD, Baris Guzel, MD, Geylan Isik, MD
PDF
105-113
Safety of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules: Review of postmarketing adverse events during the first year
Vincent C. Badalamenti, PharmD, Jill W. Buckley, PharmD, Eric T. Smith, PharmD
PDF
115-125
Do transdermal opioids affect the personal socioeconomic costs of healthcare access in an Australian rural pain population? A comparison with oral opioids
John S. Henshaw, MMed, FFPMANZCA, Judi Walker, PhD, Dom Geraghty, PhD
PDF
126-132

Case Studies

A remifentanil/ketamine sedation in surgical cancer patients having severe Parkinson’s disease: Two case reports
German Salazar, MD, Cyrus Motamed, MD
PDF
133-134

Full Issue

March/April 2012
 
PDF
73-136